Clinical Trial Update: Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial evaluating slow-release phosphatidylcholine for pancolitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Retarded Phosphatidylcholine (phosphatidylcholine (retarded-release formulation))

Snippet

Sponsor: Heidelberg University | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED